Atrial Septal Defect with Borderline Pulmonary Vascular Disease: Surgery and Long-term Oral Prostacyclin Therapy for Recalcitrant Pulmonary Hypertension

Japanese Journal of Thoracic and Cardiovascular Surgery

Volumn 52, Issue 4, 2004, Pages 213-216

  Yamauchi, Hitoshi ^a   Yamaki, Shigeo ^b   Fujii, Masahiro ^a   Saji, Yoshiaki ^a   Ochi, Masami ^a   Shimizu, Kazuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Japan Res Inst of Pulmon Vascul   (Japan)

Author keywords

Atrial septal defect; Prostacyclin; Pulmonary hypertension; Pulmonary vascular disease

Indexed keywords

PROSTACYCLIN;

ADOLESCENT; ADULT; ARTERIOLE; ARTERY DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ELASTOSIS; FEMALE; FUNCTIONAL ASSESSMENT; HEART ATRIUM SEPTUM DEFECT; HUMAN; LONG TERM CARE; LUNG VASCULAR RESISTANCE; MALE; MUSCULOELASTOSIS; OPEN LUNG BIOPSY; PATIENT CODING; PLEXOGENIC ARTERIOPATHY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; QUALITY OF LIFE; RECALCITRANT PULMONARY HYPERTENSION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 1942485850     PISSN: 13444964     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-004-0112-1     Document Type: Article

References (8)

1. Yamaki S, Horiuchi T, Miura M, Haneda K, Ishizawa E, Suzuki Y. Secundum atrial septal defect with severe pulmonary hypertension. Open lung biopsy diagnosis of operative indication. Chest 1987; 91: 33-8.
2. Wagenvoort CA, Keutel J, Mooi WJ, Wagenvoort N. Longitudinal smooth muscle in pulmonary arteries: Occurrence in congenital heart disease. Virchows Arch A Pathol Anat Histopathol 1984; 404: 265-74.
3. Yamaki S, Mohri H, Haneda K, Endo M, Akimoto H. Indications for surgery based on lung biopsy in cases of ventricular septal defect and/or patent ductus arteriosus with severe pulmonary hypertension. Chest 1989; 96: 31-9.
4. Christman BW, McPherson CD, Newman JK, King GA, Bernard GR, Groves BM, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70-5.
5. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999; 99: 1858-65.
6. Saji T, Ozawa Y, Ishikita. T, Matsuura H, Matsuo N. Short-term hemodynamic effects of a new oral PGI analogue, beraprost, in primary and secondary pulmonary hypertension. Am J Cardiol 1996; 78: 244-7.
7. Nagaya N, Shimizu Y, Satoh T, Oya H, Uematsu M, Kyotani S, et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart 2002; 87: 304-45.
8. Yamauchi H, Yamaki S, Fujii M, Iwaki H, Tanaka S. Reduction in recalcitrant pulmonary hypertension after operation for atrial septal defect. Ann Thorac Surg 2001; 72: 905-7.